Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
The Diabetes Diaries cover art

The Diabetes Diaries

The Diabetes Diaries

Written by: Rachael Sood
Listen for free

About this listen

The Diabetes Diaries is a podcast hosted by Rachael Sood, a practicing diabetologist outside of New Orleans, Louisiana and founder of the Diabetes Collective. Each episode, she sits down and talks with world leaders, experts, advocates and real people sharing their stories - all in the diabetes space. From the latest technology, cgm, pumps to groundbreaking medicine and personal journeys - this is a podcast that brings the full picture of diabetes to life that anyone can understand.


Subscribe and join a community that won’t settle for less than the best.

© 2026 The Diabetes Diaries
Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Are we transplanting Stem Cells to Cure Type 1? Apparently on the other side of the world, yesss - Dr. Andulmohsen Bakhsh
    Oct 29 2026

    Send us Fan Mail

    Sometimes the best conversations happen when you least expect them right?!!! In this episode, Rachael records a podcast in a hotel lobby coffee shop, while the tail end of a hurricane rainstorm sweeps through Philadelphia. Recorded impromptu, as our guest also happened to be waiting out the storm which delayed travel.

    Meet Dr. Abdulmohsen Bakhsh, a physician and Diabetologist from Saudi Arabia who is, quite literally, the first in the world to be officially trained in stem cell transplant therapies. After receiving his medical training in Saudi Arabia, he completed advanced fellowship training at the University of Toronto in Canada, in diabetes technologies and stem cell therapy — the only program in the world training physicians in advanced stem cell therapy.

    Dr. Bakhsh is an Adjunct Assistant Professor at Alfaisal University and was recently awarded the Young Investigator Award from the Gulf Association of Endocrinology & Diabetes, where he delivered a lecture on preventing DKA in type 1 diabetes — work from a Diabetes Canada–funded program exploring how ketone monitoring can identify people at risk, and how education works best when it's designed with patients, not just for them.

    His research focuses on immunotherapy and prevention in type 1 diabetes, and today he talks about his role as a co-investigator in clinical trials spanning immunoprevention in type 1 diabetes, plus stem cell and islet cell transplantation — the science that could one day change what living with type 1 diabetes looks like entirely.

    Recorded live from the Breakthrough T1D Clinical & Research Congress in Philadelphia — and a hotel lobby rainstorm you'll hear in the background as a bonus. This conversation is as raw and authentic as it gets, because literally it only happened by fate.

    https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

    https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

    https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

    https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9

    Show More Show Less
    29 mins
  • Anti-thymocyte globulin (ATG) for Type 1 Diabetes? And changes for the ADA? - Dr. Michael Haller,
    Oct 15 2026

    Send us Fan Mail

    In this episode, Rachael interviews a world renowned physician and clinical trialist, open to sharing details about what's happening behind the scenes in the diabetes research world when it comes to new therapies for T1D, but at a global level.

    Her guest? Leading scientist and pediatric endocrinologist from the University of Florida, Dr. Michael Haller. He answers questions about IV infusions of Teplizumab and various forms of anti-thymocyte globulin (ATG). They talk about a clinical trial called "Safeguard", which has been fast-tracked by the FDA, aiming to study a different human version of anti-thymocyte globulin (ATG).

    Dr. Haller also opens up on details surrounding events that occurred during the American Diabetes Association (ADA) Annual Scientific Sessions in June 2026, in New Orleans, Louisiana. The story actually went VIRAL in the press; even making it to the front page of the New York Times. This was after several very prominent scientists were escorted out of the conference for distributing peer-reviewed published journal articles. Since that time, a formal boycott on the ADA has been called, asking for an internal review of the events that occurred. Now, over 1000 physicians and scientific leaders have signed the boycott, yet nothing has changed. So the diabetes community continues to search for answers.

    Rachael asks Dr. Haller, "What exactly happened since you were there?" And if this boycott is honored, "Will it improve the lives of people living with diabetes?" This is the FIRST time any physician has freely spoken on camera about what actually happened, so it's an episode you WON'T want to miss.


    https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

    https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

    https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

    https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9

    Show More Show Less
    32 mins
  • Stem cells turned into islet cells: An age of Renaissance for the diabetes community - Dr. Aaron Kowalski, CEO of Breakthrough T1D
    Oct 14 2026

    Send us Fan Mail

    In this episode, Rachael podcasts live at the inaugural Breakthrough T1D Research Clinical Congress in Philadelphia, October 9-11, 2026. She interviews Dr. Aaron Kowalski, the CEO of Breakthrough T1D (formerly JDRF), about the organization and how they are funding and supporting research that ultimately will lead to cell therapies. Aaron describes details about the Vertex clinical trial, which is evaluating if infusing stem cell-derived islet cells in people living with type 1 will relieve them of their insulin dependence. It turns out, it's already worked in 10 people! And now we are just waiting for the trial to finish and release results on 38 more. Aaron is a person living with Type 1 diabetes, and even helped bring the first insulin pumps to market. Yet ironically, he states, "I believe I'll be taking my pump off" in this lifetime. Aaron even describes what the launch of commercially available cell therapies might realistically look like and provides an estimated timeline.

    If you're someone that has lost hope or ever doubted if "the cure for type 1 is almost here?", then this episode breaks it down clearly so you can understand and feel confident that we are very very close and living in a Renaissance age for Type 1 diabetes.

    https://youtube.com/@thediabetescollective?si=6gvVGtd5Um9XSb4u

    https://www.instagram.com/thediabetescollective?igsh=bGI5bno2NnUwNmp3&utm_source=q

    https://www.facebook.com/share/14mrAd3kbVj/?mibextid=wwXIfr

    https://www.tiktok.com/@thediabetescollective?_r=1&_t=ZT-97f3bZc8GU9

    Show More Show Less
    17 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet